At its highest dose, 36 mg, participants in a phase 3 trial lost an average of 12.4 percent of their starting weight over 72 weeks
Reid J, Rana K, Segel SA, Sheikh-Ali M, Choksi RR, Goldfaden RF
Yancopoulos, MD, Board Co-Chair, President & Chief Scientific Officer Number Of Employees: ~15,400 Stage: Public Financial Snapshot: The companys market cap as of July 2026 was $70.54 billion
Global Weight-Loss Deal Activity in 2025 H1: Partnerships and New Drug Investments In H1 2025, the weight-loss sector and metabolic diseases saw a flurry of dealmaking
Inno Supps and Kind Patches didnt respond to a request for comment
Its extended half-life of approximately 4.7 days is attributed to its structural design, discussed in the large molecule conjugation section of this paper